secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2025-04-17T23:59:59+00:00
Accession:  0001641172-25-005241
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq deems Hepion a 'public shell' as additional delisting basis; hearing April 29
--------------------------------------------------------------------------------

- Received Nasdaq notice on April 15, 2025, alleging company is a 'public shell' and continued listing unwarranted.
- Nasdaq Hearings Panel will consider this matter at hearing scheduled for April 29, 2025.
- Company intends to present its views on the additional deficiency at the Panel hearing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000164117225005241/0001641172-25-005241-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000164117225005241/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-005241

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer